http://www.reportbuyer.com/rss.htmlen-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/country_reports_pharmaceutical/asia_pacific_pharma_sector_analysis.htmlThe world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region has seen significant developments in the field of contract manufacturing, particularly in generics and APIs. Several technological advancements have also boosted the R&D activities in the region, helping the market to grow at double digit growth rate in recent years. c60c2d705f8f0d6b3e5347cce90b29ecWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/pharma_chemicals/snapshots_us_otc_pharmaceuticals.htmlSnapdata's Snapshots US OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US OTC pharmaceutical market and covers non-prescription cough remedies, indigestion remedies, analgesics, vitamins, cold tablets/allergy/sinus, nasal remedies, ear drops/treatments and others. Market value is based on chemists’ sales at manufacturers’ prices. fa736d3e201d68fe80ed93119196fc83Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/animal_veterinary/animal_health_report_global.htmlThe Global Animal Health Industry Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Global Animal Health Industry. 10b50e824526dfa58bff60bc52dcebbeWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/treatments/eye_care/non_linear_optical_materials_applications.htmlMaterials with highly nonlinear optical (NLO) characteristics are currently of great technological and scientific interest for diverse applications. Currently, there exists a wide range of non-linear optical materials with varied wavelengths, damage thresholds and optical characteristics. The current focus is to develop materials that meet all requirements such as faster response, high damage threshold and wide transparency range coupled with adaptability, processing ability and the ability to interface with other materials. ee8f8704cdaa661cb73b462a9f2f3323Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/cardiovascular/thrombopoiesis_stimulating_agents_tpo.htmlThe Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO, IL-11) as of November 2009 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. The product portfolio and R&D pipeline includes six products on the market, further eight clinical stage and further ten preclinical new molecules in various indications from the product categories antibody, protein, peptide and small molecule (NCE). Thrombopoiesis stimulating agents are under evaluation for treatment of idiopathic thrombocytopenic purpura (ITP) and for prevention of severe thrombocytopenia induced by chemotherapy. 34b4426402e2b89d736a802f0a8c6599Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/healthcare/biotechnology_pharmaceuticals_report_global.htmlThe Global Biotechnology Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Global Biotechnology Industry. 1fede214f6f951ce377b00aaa1bca759Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/production_manufacturing/pharmaceutical_manufacturers_report_indian.htmlThe Indian Pharmaceutical Manufacturers Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Indian Pharmaceutical Manufacturers Industry. 92c35a91b760b355a9facf046dc61244Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/biotechnology/probiotics_1.htmlProbiotics are considered to be the vital healthcare concept of the 21st century. As people become increasingly health conscious, preventive medicine in the form of probiotic foods is gaining popularity. While already widely known and put to extensive use by Asians and Europeans, the trend for probiotics is catching up with the world populace. 2e07d387841ecbaf28fe0c1eef9f67a8Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/medical_devices/medical_imaging_markets_contrast_agents.htmlThe application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets. 04e78ba37204894652d8d241c48c5576Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/healthcare/biopharmaceuticals_industry_report_global.htmlThe Global Biopharmaceuticals Industry Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Global Biopharmaceuticals Industry. d12dc5686810135084dad38288151783Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/pharma_chemicals/snapshots_us_pharmaceuticals.htmlSnapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and covers Prescription and OTC Pharmaceuticals. Market value is based on sales. 07950074c79374427a4adf7f8a3c66c7Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/production_manufacturing/top_100_pharmaceutical_manufacturers_industry_analysis_worldwide.htmlThe Global Top 100 Pharmaceutical Industry Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Global Top 100 Pharmaceutical Industry. f3274b1d944178bdad36295ff06c57fcWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/biotechnology/biometrics.htmlIncreasing security concerns ranging from individual identity theft, corporate security, to even national security represents factors that are important to the biometrics market. Some countries have already rolled out biometric systems at airports and other ports of entry to check flow of illegal immigrants into their respective territories. On the technological front, non-contact systems could emerge as the answer to expel inhibitions exhibited by users. 37ea91add5c2d64f619acdc6619a7889Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/biotechnology/proteomics.htmlThe shift from genomics to proteomics paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput and increased resolution from traditional protein research tools. A major market growth driver is the explosion in scientific discoveries arising from the human genome project and from advances in high-throughput technologies for protein studies. Companies from diverse areas such as contract research, computational science, outsourced drug discovery services, database administration and integration, software manufacture, genomics and genetics, operate in the industry. 8e64c2d40eec0f7708de7ba8dbcf5b76Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/pharma_chemicals/snapshots_hungary_pharmaceuticals.htmlSnapdata's Snapshots Hungary Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Hungarian pharmaceutical market and covers prescription and OTC pharmaceuticals. Market value is based on sales. 38beccd35092ba9f594094016e0755dcWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/production_manufacturing/pharmaceutical_manufacturers_report_chinese.htmlThe Chinese Pharmaceutical Manufacturers Report Do you know. . . . The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation of the Chinese Pharmaceutical Manufacturers Industry. cb0cdbb1ddf1fdf1cc6f88457f150677Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/biotechnology/automated_rapid_microbiological_tests_1.htmlHigh prevalence of infectious diseases and sexually transmitted diseases (STDs) continue to drive the automated and rapid tests market, as need for quicker, higher volume and more accurate methods of testing gains importance. With humans and bacteria locked in a perennial biological warfare, there exists a perpetual need for new and advanced rapid microbial testing methods and instruments. Hitherto growth in the automated microbiological test systems market stemmed from laboratories worldwide embarking on the transition from manual to automated forms of testing. 2c4b73d3a8eb5d296fbfa198261cf9bcWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/pharma_chemicals/snapshots_denmark_otc_pharmaceuticals.htmlSnapdata's Snapshots Denmark OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Danish OTC pharmaceutical market and covers the total consumption of OTC medicine in Denmark divided into therapeutic groups, measured in wholesale prices, Danish Kroner (DKK) 1,000. Market Value is based on consumption in wholesale prices. 020d1f803a3f2bc5a2eb180c47893ddcWed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/medical_devices/gastointestinal_gi_endoscopy_devices_worldwide_2009.htmlThis research report analyzes the world market for Gi endoscopy devices and accessories. The report discusses key players and identifies trends impacting the market for these products. Topics covered include product definitions, revenue and implantation projections, strategies, competitive analysis, key market and product segment parameters, market shares, competitive position maps, market conditions, brands and models, and company profiles. e70468a20cac953f3295280b3ce9abd4Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcarehttp://www.reportbuyer.com/pharma_healthcare/biotechnology/chiral_technology.htmlThe fast developing small molecule chiral technology sector is witnessing a flurry of activity with pharmaceutical companies adding chiral expertise to their portfolios. Several leading pharmaceuticals such as Lipitor, Zocor, Advair, Norvasc and Viagra are chiral based. While conventional processes of chiral production such as resolution and chiral pool chemistry are time-tested methods, emerging asymmetric and biological methods are also the focus of attention, garnering significant research dollars. 1b31623d442c81bf668190a533c8b5bdWed, 11 Nov 2009 12:00:00 GBPharma & Healthcare